A record search of the VA Wadsworth Hospital Center was undertaken to review the charts of all the patients found to have hypouricaemia (defined as two or more consecutive serum urate concentrations of less than 2-2 mg/100 ml, measured by an autoanalyser) during one calendar year. The age, sex, race, and clinical or postmortem diagnosis were determined. Serum urate concentration and biochemical evidence of liver disease, including serum bilirubin, alkaline phosphatase, and serum proteins, were measured by autoanalyser (Sobrinho-Simoes, 1965) . The recent use of cholecystographic agents and drugs which alter the serum urate was also noted. Finally the subsequent course of the patients under review was determined when that information was available.
PROSPECTIVE STUDY OF JAUNDICED PATIENTS
Five patients with hyperbilirubinaemia (2 with Australia antigen-associated hepatitis, 1 with halothane-sensitivity hepatitis, 1 with alcoholic cirrhosis, and 1 with gallstone obstruction of the common bile duct) were studied while jaundiced and for up to 10 weeks (mean 5 weeks) after complete or partial remission of jaundice. All jaundiced patients who were observed on the wards were considered for inclusion in the study. Fifteen patients were studied with collections of 24-hour urinary uric acid and serum urate. Only in five patients was it possible to obtain a second 24-hour urinary uric acid and serum urate. These were the patients included in this report.
Blood was collected, allowed to clot, then immediately centrifuged, and the serum frozen and stored at -20°C for up to one month before biochemical determinations. Bilirubin concentrations were assayed the day the blood was drawn. Urine was collected for a 24-hour period at room temperature with 3 ml toluene as a preservative. Urine aliquots were taken after measurement of the volume of the total sample and stored at -20°C for periods up to one month before determination of uric acid and creatinine.
Uric acid determinations were performed by an enzymatic spectrophotometric method (Liddle, Seegmiller, and Laster, 1959) , total bilirubin was measured by a autoanalyser, total protein by the biuret method (Gornall, Bardawill, and David, 1949) , and albumin after separation of serum proteins by the Beckman microzone electrophoresis system. Binding of urate to plasma proteins was determined as described below.
None of these prospectively studied patients was taking drugs, such as salicylate, known to alter serum urate or binding of urate to serum protein (Bluestone and others, 1969) . The patient with gallstones was studied by oral cholecystography using iopanoic acid two weeks before obtaining the first urine and serum samples for the present study. This was after a period that is considerably longer than the known uricosuric activity of cholecystographic agents reported (Mudge, 1971; Postlethwaite and Kelley, 1971 (Klinenberg and Kippen, 1970) . The excess urate concentration inside the bag at the end of the dialysis, compared to the urate concentration in the dialysing fluid, was considered bound to proteins in the plasma.
Results

RETROSPECTIVE PATIENT STUDY
Twenty-two out of 4,148 patients, screened by autoanalyser, during the year had hypouricaemia. Table I summarizes the clinical data available for fifteen of these 22 patients. The remaining charts could not be located. The age range of the patients (41 to 75 years) was representative of the overall population of the hospital. There were two women patients and thirteen men patients, reflecting the male predominance expected in the hospital.
Five of the fifteen patients had liver disease and jaundice: either cirrhosis resulting from alcoholism or metastatic disease. Four of these subsequently died and one was lost to follow-up. Four other patients were taking drugs known to be uricosuric. One of these four was taking both hydrochlorothiazide and high-dosage aspirin (the former drug raises serum urate when given chronically, and the latter lowers serum urate by impairing tubular urate reabsorption). Two others in this group were taking high-dosage aspirin. The last of these four patients (who had adenocarcinoma of the lung as well) was given dexamethasone, a drug reported to be uricosuric (Sprague, Power, Mason, Albert, Mathieson, Hench, Kendall, Slocomb, and Polley, 1950) . Of the remaining six patients, three had chronic alcoholism, one with associated maturity onset diabetes mellitus, and another had associated chronic osteomyelitis of the femur and was undergoing extended treatment with tetracycline. The other three patients had carcinoma. One had bronchogenic carcinoma and mild diabetes mellitus controlled without drugs; at necropsy no liver metastases were found. Another had carcinoma of the oropharynx and died of ventilatory obstruction, but showed no evidence of liver involvement at necropsy. The final patient had carcinoma of the retromandibular area and tonsillar pillar without clinical evidence of liver disease.
PROSPECTIVE STUDY OF JAUNDICED PATIENTS
Shown in Table II 
Discussion
The clinical observation that hypouricaemia is unusual was confirmed by our finding only 22 patients with serum urate below 2-2 mg/100 ml in a review of 4,148 uric acid determinations. Lawee (1969) reviewed 1,000 unsolicited uric acid determinations and found 58 patients with uric acid below 2-6 mg/ 100 ml. He listed numerous diagnoses associated with hypouricaemia, including neoplasms, diabetes mellitus, arteriosclerotic heart disease, and epilepsy. Bennett, Bond, Singer, and Gottlieb (1972) (Pasero and Masini, 1959) . They concluded that the increased urate clearance was caused by impaired tubular reabsorption of urate due to damage to the renal tubules. However, the possible biological role of bilirubin as a uricosuric agent has not previously received serious consideration. Previous observations in our laboratories (Bluestone and others, 1969) Thus, the clinical observation of hypouricaemia in jaundiced patients seems to be a true one and could be related to increased urate clearance caused by bilirubin acting as a uricosuric agent.
Summary
On screening 4,148 patients at a general hospital during one year, only 05 % had confirmed plasma urate levels of less than 2-2 mg/100 ml. The hypouricaemia was usually associated with severe hepatic disease and jaundice. To determine whether the apparent association between hypouricaemia and hyperbilirubinaemia was a real one, the relationship between plasma urate and bilirubin was studied in five transiently jaundiced patients during their acute illness and later after complete or partial recovery. The mean serum bilirubin fell from 11 1 to 2-3 mg/ 100 ml as the patients recovered. This was accompanied by (1) a rise in mean serum urate from 4-6 to 5 8 mg/100 ml; (2) a mean decrease in renal urate clearance of 3-2 ml/min; (3) 
